BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2002
View Archived Issues
BMOV enters phase II for treatment of severe burns in children
Read More
Potential for Ono-AE1-329 in the treatment of inflammatory bowel disease
Read More
Edrecolomab effective against bone marrow metastases of breast cancer
Read More
Further data on efficacy and safety of deferiprone in beta-thalassemia
Read More
RPR-109881A: pharmacokinetics in patients with advanced solid tumors
Read More
GLP-1 and its analogue LY-315902 inhibit intestinal motility and reduce plasma somatostatin
Read More
Recent studies support Pyridorin as a potentially important advance in diabetic nephropathy
Read More
Oralin compares favorably with s.c. insulin after a meal in type 1 and 2 diabetes
Read More
Pharmacokinetics/pharmacodynamics of inhaled insulin investigated in different patient populations
Read More
Aminoglycoside antibiotics identified by Wayne State U. researchers
Read More
Merck researchers present new NK1 antagonists for pain, emesis, etc.
Read More
Merck & Co. presents new thrombin inhibitors
Read More
NAALADase inhibitors synthesized and tested at Guilford
Read More
First regulatory filing for an HIV fusion inhibitor
Read More
New ileal bile acid transport inhibitors in the Sankyo pipeline
Read More
Sankyo patent covers new triazole antifungal agents
Read More
Inhibitors of IL-4 production with potential in asthma, allergy and other disorders
Read More
Synthetic secretin available for diagnosing pancreatic dysfunction and gastrinoma
Read More
Transdermal PTH-based product in development for osteoporosis
Read More
Selective NK1 antagonist derived from dual NK1/NK2 antagonist at AstraZeneca
Read More
Lundbeck and Abbott to copromote Lexapro in Latin America
Read More
Phase II Ceplene triple-drug trial cleared to continue
Read More
Phase II IND cleared for NCX-701
Read More
MLN-02 fails to meet primary endpoint in phase II Crohn's disease trial
Read More
Patient enrollment completed in phase II MC-1 trial
Read More
Wyeth advances NSP-989 into the clinic
Read More
Diachrome evaluated for ability to improve blood glucose control in type 2 diabetes patients
Read More